36

DEDICATED PROFESSIONALS

282

DEALS CLOSED

52

LIVE MANDATES

Oaklins' professionals understand the regulatory, reimbursement, technological, medical and patient environments locally and around the world. We know the key players and can take a global perspective on any M&A deal. We identify the right strategic partners, maximize synergy potential and realize premium valuations for our clients. That's the Oaklins way.

Global Deals

Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image

Oaklins Healthcare Specialists

Africa

South Africa, Johannesburg

Yaron Zimbler

Americas

Canada, Montreal

Pierre Mathieu

Mexico, Mexico City

Alejandro Rocha

United States, Chicago

Arthur J. Lyman

United States, Cleveland

Andrew P. Male

United States, Dallas

Mark Lee

United States, Jacksonville

Don Wiggins

United States, Los Angeles

Jonathan Bluth

United States, New York

Michael S. Goldman

United States, Seattle

Scott Hardman

Asia Pacific

Australia, Sydney

Peter Fraser

China, Hong Kong

Adrian Bradbury

Japan, Tokyo

Taro Okayama

Singapore, Singapore

Alistair Burgoyne

Europe and Middle East

Croatia, Zagreb

Željko Perić

Czech Republic, Prague

David Tajzich

Denmark, Copenhagen

Frederik Aakard

Estonia, Tallinn

Lauri Isotamm

Finland, Helsinki

Mikael Planting

France, Paris

Jean-Paul Ortelli

Germany, Hamburg

Christian Jellentrup

Germany, Stuttgart

Matthias Knoke

Ireland, Dublin

David Lyons

Israel, Tel Aviv

Boaz Levi

Italy, Milan

Marco A. Vismara

Latvia, Riga

Anna Aile

Lithuania, Vilnius

Karolis Pocius

Netherlands, Amsterdam

Robert Boersma

Norway, Oslo

Odd Paulsen

Poland, Warsaw

Maciej Szalaj

Russia, Moscow

Alexey Bykov

Slovakia, Bratislava

Michal Staron

Slovenia, Ljubljana

Jure Jelerčič

Spain, Madrid

José Antonio Martín de los Santos

Sweden, Gothenburg

Sven-Åke Lewin

Sweden, Stockholm

Adel Koubaa

Switzerland, Bern

Roberto Tracia

United Kingdom, London

Amanda Phillips

United Kingdom, London

Michael Jewell

RECENT OAKLINS
NEWS & PUBLICATIONS

Oaklins’ team in Russia will join SFM Group at the BIO 2017

Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections,…

READ MORE

Globalizing cutting edge technology in point-of-care patient blood management

HEALTHCARE DEAL FLASH: Oaklins’ team in Switzerland advised the shareholders of TEM Group on the sale of the company to Instrumentation Laboratory (IL). The team acted as lead advisor to the shareholders of TEM Group throughout the sale process. This deal demonstrates the value and competitive advantage Oaklins provides in guiding the client in a very…

READ MORE

Shareholder Succession at Sphinx Werkzeuge AG

The owners of Sphinx Werkzeuge AG have sold a majority stake in the company to Helvetica Capital AG and members of the management team. Financial details were not disclosed. Sphinx Werkzeuge is a leading precision tools developer and manufacturer for high precision mechanical and medical applications. The company’s core business is the production of micro…

READ MORE

Instrumentation Laboratory Acquires CA CASYSO AG, Including TEM® subsidiaries and ROTEM® Testing Systems

Instrumentation Laboratory (IL) acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a global leader in in vitro diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. Tem is a global leader in in-vitro-diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. With…

READ MORE

A new rehabilitation pathway for acquired brain injuries

HEALTHCARE DEAL FLASH:  Smith & Williamson advised the shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) on the sale of the company to CareTech Holdings Plc (CareTech). Oakleaf provides brain injury rehabilitation to adult males requiring specialist care and long-term support. The in-depth healthcare sector knowledge and experience of our team of advisors was crucial to…

READ MORE

Cross-border deal in biosimilars

HEALTHCARE DEAL FLASH:  Oaklins’ Swedish and Italian teams advised the shareholders of Xbrane Biosciences AB (Xbrane) on the acquisition of Primm Pharma. They supported the buyer by scouting the Italian market, identifying the most suitable target, and assisting in the LOI formulation and in negotiations throughout the process. Through the acquisition, Xbrane will be able…

READ MORE

Consolidation continues in the dental industry

HEALTHCARE DEAL FLASH:  Our Oaklins’ team in the Netherlands and Cavendish, an Oaklins member firm in the UK, advised the shareholders of C.D.C. Complete tandzorg (CDC) in the sale of a stake in the company to G Square Healthcare Private Equity. The partnership will enable CDC to expand its dental care services to other regions…

READ MORE